Long-term outcomes with intensive induction chemotherapy (carboplatin, bleomycin, vincristine and cisplatin/bleomycin, etoposide and cisplatin) and standard bleomycin, etoposide and cisplatin in poor prognosis germ cell tumours: A randomised phase II trial (ISRCTN53643604)-Reference-Cited by-同舟云学术

Long-term outcomes with intensive induction chemotherapy (carboplatin, bleomycin, vincristine and cisplatin/bleomycin, etoposide and cisplatin) and standard bleomycin, etoposide and cisplatin in poor prognosis germ cell tumours: A randomised phase II trial (ISRCTN53643604)

Published:2020-03 Issue: Volume:127 Page:139-149
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Cafferty Fay H.,White Jeff D.,Shamash Jonathan,Hennig Ivo,Stenning Sally P.,Huddart Robert A.

Funder

Cancer Research UK

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference18 articles.

1. International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers;J Clin Oncol,1997

2. A randomised phase 2 trial of intensive induction chemotherapy (CBOP/BEP) and standard BEP in poor-prognosis germ cell tumours (MRC TE23, CRUK 05/014, ISRCTN 53643604);Huddart;Eur Urol,2015

3. Personalised chemotherapy based on tumour marker decline in poor prognosis germ-cell tumours (GETUG 13): a phase 3, multicentre, randomised trial;Fizazi;Lancet Oncol,2014

4. Vincristine, cisplatin, and bleomycin with surgery in the management of advanced metastatic nonseminomatous testis tumors;Wettlaufer;Cancer,1984

5. Randomized comparison of cisplatin and etoposide and either bleomycin or ifosfamide in treatment of advanced disseminated germ cell tumors: an Eastern Cooperative Oncology Group, Southwest Oncology Group, and Cancer and Leukemia Group B Study;Nichols;J Clin Oncol,1998

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Personalized Chemotherapy on the Basis of Tumor Marker Decline in Poor-Prognosis Germ-Cell Tumors: Updated Analysis of the GETUG-13 Phase III Trial;Journal of Clinical Oncology;2024-08-21

2. Programmed cell death, redox imbalance, and cancer therapeutics;Apoptosis;2021-07-08